| S6887 |
Clozapine N-oxide (CNO chemical)
|
CNO (Clozapine N-oxide) is a metabolite of Clozapine (GLXC-06516) and an agonist of human muscarinic designer receptors (Designer Receptors Exclusively Activated by Designer Drugs, DREADDs). Clozapine is a potent dopamine (DA) antagonist and a selective muscarinic M4 receptor agonist.Solutions are unstable and should be fresh-prepared.
|
-
Theranostics, 2025, 15(5):1822-1841
-
STAR Protoc, 2025, 6(1):103542
-
Theranostics, 2024, 14(7):2881-2896
|
|
| S5749 |
Chlorpromazine
|
Chlorpromazine (CPZ) is a low-potency typical antipsychotic agent that is used to treat psychotic disorders such as schizophrenia. This compound inhibits 5-HT(2A) receptor and dopamine D2 in vitro. It also inhibits sodium channel and blocks HERG potassium channels with IC50 of 21.6 μM.
|
-
EMBO J, 2025, 10.1038/s44318-025-00537-7
-
Mol Psychiatry, 2025, 10.1038/s41380-025-03374-6
-
J Thromb Haemost, 2025, 23(9):2926-2943
|
|
| S4732 |
MPTP Hydrochloride
|
MPTP hydrochloride is a dopaminergic neurotoxin and cause selective destruction of dopaminergic neurons in animal models of parkinsonism. MPTP hydrochloride induces apoptosis.MPTP hydrochloride can be used to induce animal models of Parkinson’s disease.
|
-
Inflammation, 2025, 10.1007/s10753-025-02306-4
-
Front Aging Neurosci, 2025, 17:1551404
-
Exp Cell Res, 2025, 449(2):114602
|
|
| S2456 |
Chlorpromazine HCl
|
Chlorpromazine HCl is a dopamine and potassium channel inhibitor with IC50 of 6.1 and 16 μM for inward-rectifying K+ currents and time-independent outward currents.
|
-
J Colloid Interface Sci, 2024, 664:338-348
-
Virus Res, 2024, 339:199258
-
Cell Mol Immunol, 2022, 19(8):925-943
|
|
| S5856 |
Trifluoperazine
|
Trifluoperazine (NSC-17474, RP-7623, SKF-5019) is an FDA-approved antipsychotic drug for schizophrenia. It is an inhibitor of calmodulin (CaM) and Dopamine D2 receptor with an IC50 value of 1.2 nM for D2 receptor.
|
-
Toxicol Appl Pharmacol, 2025, 500:117393
-
Glia, 2024,
-
Chem Biol Interact, 2024, 395:111023
|
|
| S3201 |
Trifluoperazine 2HCl
|
Trifluoperazine (NSC-17474, RP-7623, SKF-5019) 2HCl is a dopamine D2 receptor inhibitor with IC50 of 1.1 nM. Trifluoperazine also inhibits calmodulin (CaM).
|
-
Theranostics, 2025, 15(17):9073-9090
-
Antiviral Res, 2024, 222:105817
-
Front Microbiol, 2022, 13:979904
|
|
| S2529 |
Dopamine HCl
|
Dopamine HCl(ASL279, NSC 173182) is a catecholamine neurotransmitter present in a wide variety of animals,And a dopamine D1-5 receptors agonist.
|
-
iScience, 2023, 26(3):106241
-
Cell Rep Methods, 2023, 3(10):100599
-
Front Microbiol, 2022, 13:979904
|
|
| S4151 |
Penfluridol
|
Penfluridol (TLP-607,R-16341) is a highly potent, first generation diphenylbutylpiperidine antipsychotic.
|
-
Signal Transduct Target Ther, 2025, 10(1):341
-
Transl Oncol, 2025, 62:102559
-
Acta Pharm Sin B, 2022, 12(3):1271-1287
|
|
| S4631 |
Prochlorperazine dimaleate salt
|
Prochlorperazine dimaleate salt is a dopamine (D2) receptor antagonist.
|
-
Cell Rep Med, 2025, 6(11):102421
-
Cancer Biol Ther, 2023, 24(1):2269637
-
Cancer Biol Ther, 2023, 10.1080/15384047.2023.2269637
|
|
| S1763 |
Quetiapine (ICI-204636) fumarate
|
Quetiapine Fumarate (ICI-204636) is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression and shows affinity for various neurotransmitter receptors including serotonin, dopamine, histamine, and adrenergic receptors.
|
-
Front Microbiol, 2022, 13:979904
-
Clin Transl Sci, 2021, 10.1111/cts.13012
-
J Cancer Res Clin Oncol, 2019, 145(6):1495-1507
|
|